Advancing Treatment of von Willebrand Disease: A Visual Exploration on Personalizing Care with Current and Emerging Management Strategies

Live and On-Demand Activities

Filter Activities

Clear

Visualizing Progress With BTK Inhibitors: An Animated Journey Through the Mechanisms of Covalent and Non-Covalent Options

0.50 hr(s) | ABIM , CME , MOC

Specialty: BTK

Therapeutic Area(s): Hematology, Benign , Oncology

Release Date: November 19, 2021

Expiration Date: November 18, 2022

Location: Internet Activity Enduring

It’s well known that the BTK inhibitor agent class is highly effective across several B-cell malignancies, including chronic lymphocytic leukemia and mantle cell lymphoma. Less well understood are the factors that can limit the effectiveness of covalent BTK inhibitors and the emerging strategies that can overcome therapeutic resistance and intolerance, which provide a new option for managing relapsed disease. In this animated, visually enhanced activity, a hematology-oncology expert outlines the clinically relevant mechanistic aspects of covalent and noncovalent BTK inhibitors, mechanisms and patterns of resistance to covalent agents, and rationale for integrating novel approaches to combatting resistance and intolerance.

Strategies To Improve Glucose Control with Mealtime Insulin-December 20

.75 hr(s) | CME , CPE , NCPD

Specialty: Diabetes , Endocrinology

Therapeutic Area(s): Diabetes , Endocrinology

Release Date: December 20, 2021

Expiration Date: TBD

Location:

Medical Learning Institute, Inc., the Endocrine Society, and the National Committee for Quality Assurance are offering 2 live social media-based educational activities that will recap key points and address questions from clinicians regarding the optimal use of mealtime insulin to control blood glucose levels.

Strategies To Improve Glucose Control with Mealtime Insulin-December 1, 2021

.75 hr(s) | CME , CPE , NCPD

Specialty: Diabetes , Endocrinology

Therapeutic Area(s): Diabetes , Endocrinology

Release Date: December 1, 2021

Expiration Date: TBD

Location:

Medical Learning Institute, Inc., the Endocrine Society, and the National Committee for Quality Assurance are offering 2 live social media-based educational activities that will recap key points and address questions from clinicians regarding the optimal use of mealtime insulin to control blood glucose levels.

Visualizing Progress in the Management of Chronic Spontaneous Urticaria: Harnessing the Clinical Potential of New and Novel Therapies to Address Unmet Patient Needs

0.5 hr(s) | CME

Specialty: Chronic Spontaneous Urticaria

Therapeutic Area(s): Dermatology

Release Date: November 11, 2021

Expiration Date: November 10, 2022

Location: Internet Activity Enduring

In this animated activity, an expert in dermatology discusses new and novel therapies addressing unmet patient needs in the management of chronic spontaneous urticaria (CSU).

Overcoming the Challenges of Diverse TGCT Presentations: Diagnostic and Treatment Principles for the Multidisciplinary Team

0.50 hr(s) | ABIM , CME , MOC , Royal College of Physicians and Surgeons of Canada

Specialty: tenosynovial giant cell tumor

Therapeutic Area(s): Oncology

Release Date: October 29, 2021

Expiration Date: October 28, 2022

Location: Internet Activity Enduring

Despite the widespread use of surgery as a standard of care for tenosynovial giant cell tumor (TGCT), several therapeutic challenges remain, particularly in the setting of diffuse TGCT, where recurrent and difficult-to-treat disease can be present. In this activity, an orthopedic surgeon and medical oncologist debate the case-based management of challenging TGCT presentations, and illustrate the nuances of multidisciplinary collaboration when managing patients with TGCT. Throughout, the panelists profile a modern management synthesis that combines surgery, physical therapy, and the use of targeted agents, including for patients for whom surgery alone is unlikely to be beneficial.

Integrating the Latest Evidence into Practice: Expert Insights on Targeted Biologic Therapy for Pediatric and Adult Patients with Moderate to Severe Atopic Dermatitis

0.50 hr(s) | CME

Specialty: Atopic Dermatitis

Therapeutic Area(s): Dermatology

Release Date: October 20, 2021

Expiration Date: October 19, 2022

Location: Internet Activity Enduring

In this activity, an expert dermatologist discusses the latest evidence from the 30th European Academy of Dermatology and Venereology Congress for current and emerging targeted biologic therapies for moderate to severe atopic dermatitis in adults and children.

Advancing Treatment of von Willebrand Disease: A Visual Exploration on Personalizing Care with Current and Emerging Management Strategies

0.50 hr(s) | CME

Specialty: von Willebrand Disease

Therapeutic Area(s): Hematology, Malignant

Release Date: October 15, 2021

Expiration Date: October 14, 2022

Location: Internet Activity Enduring

In this activity, a hematology expert discusses the diagnostic assessment and management of von Willebrand disease, as well as available treatment options and strategies for shared decision-making.

1 2 3 16
Copy link
Powered by Social Snap